Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Read moreNing Tang et al. J Thromb Haemost. 2020
Applications – Covid-19
Showing all 9 results
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Read moreRao Guo et al.JAMA Cardiol. 2020
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Read moreFei Zhou et al. Lancet. 2020 28;395(10229):1054-1062
Critically Ill COVID-19 Infected Patients Exhibit Increased Clot Waveform Analysis Parameters Consistent with Hypercoagulability.
Read moreChuen Wen Tan et al. Am J Hematol. 2020
Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19.
Read moreYong Gao et al. J Med Virol. 2020
Jecko Thachil et al. J Thromb Haemost. 2020
Management of COVID‐19 Related Paediatric Blood Samples in a Clinical Haematology Laboratory
Read moreLam JC et al. British Journal of Haematology. 2020 doi: 10.1111/bjh.16721
Huan Han et al. Clin Chem Lab Med. 2020
Temporal Changes in Immune Blood Cell Parameters in COVID‐19 Infection and Recovery from Severe Infection
Read moreYip, Christina YC, et al. British Journal of Haematology. 2020 doi: 10.1111/bjh.16847